Optimal insulin tratment in experimental islet transplantation

dc.contributor.author
Merino, Juan F.
dc.contributor.author
Nacher, Victor
dc.contributor.author
Raurell, Mercè
dc.contributor.author
Biarnés Costa, Montse
dc.contributor.author
Soler Ramon, Joan
dc.contributor.author
Montanya Mias, Eduard
dc.date.issued
2019-06-06T14:48:04Z
dc.date.issued
2019-06-06T14:48:04Z
dc.date.issued
2000-02
dc.date.issued
2019-06-06T14:48:05Z
dc.identifier
0963-6897
dc.identifier
https://hdl.handle.net/2445/134709
dc.identifier
537256
dc.identifier
10784061
dc.description.abstract
Insulin-induced normoglycemia has shown to have a beneficial effect on the outcome of pancreatic islets transplanted to diabetic recipients. The aim of the study was to identify the insulin treatment that can maximize its beneficial effect on islet transplants. Six groups of streptozotocin diabetic C57Bl/6 mice were transplanted (Tx) with 100 syngeneic islets, an insufficient beta cell mass to restore normoglycemia, and were treated with insulin as follows: group 1 (n = 9): from day 10 before Tx to day 14 after Tx; group 2 (n = 11): from day 6 before Tx to Tx day; group 3 (n = 11): from Tx day to day 6 after Tx; group 4 (n = 7): from Tx day to day 14 after Tx; group 5 (n = 8): from day 10 to day 24 after Tx; group 6 (n = 18): Tx mice were not treated with insulin. Sixty days after Tx, normoglycemia was achieved in 100% of mice in groups 1, 4, and 5, in 73% of mice in group 2, and in only 45% and 33% of mice in groups 3 and 6, respectively (p < 0.01). Intraperitoneal glucose tolerance, determined only in normoglycemic mice, was similar in groups 1, 2, 4, and normal controls. In contrast, normoglycemic mice from groups 3, 5, and 6, exposed to more severe and prolonged hyperglycemia after Tx, showed higher glucose values after glucose injection, suggesting that hyperglycemia had a long-lasting deleterious effect on transplanted beta cell function. The initially transplanted beta cell mass was maintained in the grafts of normoglycemic mice, but was severely reduced in hyperglycemic mice. Transplanted beta cell mass was similar in normoglycemic groups with normal or impaired glucose tolerance, indicating that impaired glucose tolerance was not due to reduced beta cell mass. In summary, the beneficial effect of insulin-induced normoglycemia on transplanted islets was maximal when insulin treatment was maintained the initial 14 days after transplantation. Exposure to sustained hyperglycemia initially after transplantation had a long-lasting deleterious effect on transplanted islets.
dc.format
8 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
Cognizant Communication Corporation
dc.relation
Reproducció del document publicat a: https://doi.org/10.1177/096368970000900102
dc.relation
Cell Transplantation, 2000, vol. 9, num. 1, p. 11-18
dc.relation
https://doi.org/10.1177/096368970000900102
dc.rights
cc-by-nc (c) Cognizant Communication Corporation, 2000
dc.rights
http://creativecommons.org/licenses/by-nc/3.0/es
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Ciències Clíniques)
dc.subject
Insulina
dc.subject
Diabetis
dc.subject
Cirurgia
dc.subject
Antidiabètics
dc.subject
Illots de Langerhans
dc.subject
Insulin
dc.subject
Diabetes
dc.subject
Surgery
dc.subject
Hypoglucemic agents
dc.subject
Islands of Langerhans
dc.title
Optimal insulin tratment in experimental islet transplantation
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Fitxers en aquest element

FitxersGrandàriaFormatVisualització

No hi ha fitxers associats a aquest element.

Aquest element apareix en la col·lecció o col·leccions següent(s)